ADENOCOR INJECTION 3MG/ML

Product Information

Registration Status: Active

ADENOCOR INJECTION 3MG/ML is approved to be sold in Singapore with effective from 1994-05-04. It is marketed by SANOFI-AVENTIS SINGAPORE PTE LTD, with the registration number of SIN07679P.

This product contains Adenosine 6mg/2ml in the form of INJECTION. It is approved for INTRAVENOUS use.

This product is manufactured by Famar Health Care Services Madrid in SPAIN.

It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.

Adenosine

Description

Bovine adenosine deaminase derived from bovine intestine that has been extensively pegylated for extended serum half life.

Indication

For treatment of adenosine deaminase deficiency

Mechanism of Action

Pegademase converts adenosine (toxic) to inosine (less toxic) by deamination. It also converts 2'-deoxyadenosine to 2'-deoxyinosine via deamination.

Pharmacokinetics

Absorption
Time to peak for plasma adenosine deaminase is 2 to 3 days
Distribution
Metabolism
Elimination

Active Ingredient/Synonyms

Adenosine aminohydrolase | Adenosine deaminase | Pegademase bovine |


Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank